Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy

American Journal of Kidney Diseases

Volumn 42, Issue 2, 2003, Pages 286-294

  Danielski, Michael ^b   Ikizler, T Alp ^b   McMonagle, Ellen ^b   Kane, Jane Conner ^b   Pupim, Lara ^b   Morrow, Jason ^b   Himmelfarb, Jonathan ^a  

^a MAINE MEDICAL CENTER   (United States)

^b NONE

Author keywords

Albumin; C reactive protein (CRP); Cytokine; Dialysis; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; INTERLEUKIN 6; ISOPROSTANE; ISOPROSTANE F 2; PLASMA PROTEIN; PREALBUMIN; SERUM ALBUMIN; THIOL; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; INFECTION; INFLAMMATION; MAINTENANCE THERAPY; MALE; MEASUREMENT; OXIDATION; OXIDATIVE STRESS; PREVALENCE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

EID: 0043128853     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00653-X     Document Type: Article

References (53)

1. Baigent C, Burbury K, Wheeler D: Premature cardiovascular disease in chronic renal failure. Lancet 356:147-152, 2000
2. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119, 1998 (suppl 3)
3. US Renal Data System: Survival, mortality and causes of death. Am J Kidney Dis 36:S127-S142, 2000 (suppl)
4. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
5. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44:115-119, 1993
6. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006, 1993
7. Mitch WE: Malnutrition: A frequent misdiagnosis for hemodialysis patients. J Clin Invest 110:437-439, 2002
8. Stenvinkel P, Heimburger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 51:1899-1911, 1999
9. Kaysen GA: Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 9:2368-2376, 2000
10. Kaysen GA, Dubin JA, Müller HG, Rosales LM, Levin NW, Hemo Study Group: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 58:346-352, 2000
11. Kaysen GA, Chertow GM, Adhikarla R, Young B, Ronco C, Levin NW: Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60:333-340, 2001
12. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
13. Owen WF, Lowrie EG: C-Reactive protein as an outcome predictor for maintenance hemodialysis patients. Nephrol Dial Transplant 54:627-636, 1998
14. Arici M, Walls J: End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 59:407-414, 2001
15. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476, 2000
16. Kato A, Odamaki M, Takita T, Maruyama Y, Kumagai H, Hishida A: Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 61:1143-1152, 2002
17. Stenvinkel P, Heimburger O, Jogestrand T: Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 39:274-282, 2002
18. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684-1688, 2002
19. Kalantar-Zadeh K, Kopple JD, Block G, Humphries MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251-1263, 2001
20. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524-1538, 2002
21. Hasselwander O, Young IS: Oxidafive stress in chronic renal failure. Free Radic Res 29:1-11, 1998
22. Galli F, Canestrari F, Bellomo G: Physiopathology of the oxidative stress and its implications in uremia and dialysis. Contrib Nephrol 127:1-31, 1999
23. Tetta C, Biasioli S, Schiavon R, et al: An overview of haemodialysis and oxidative stress. Blood Purif 17:118-126, 1999
24. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER: Oxidative stress in haemodialysis. Q J Med 87:679-683, 1994
25. Roselaar SE, Nazhat JB, Winyard PG, Jones P, Cunningham J, Blake DR: Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int 48:199-206, 1995
26. Nguyen-Khoa T, Massy ZA, Pascal De Bandt J, et al: Oxidative stress and haemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16:335-340, 2001
27. Halliwell B: Commentary: Albumin - An important extracellular antioxidant? Biochem Pharmacol 37:569-571, 1988
28. Himmelfarb J, McMonagle E: Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60:358-363, 2001
29. Stenvinkel P, Holmberg I, Heimburger O, Diczfalusy U: A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure: Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 13:2594-2600, 1998
30. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77, 1959
31. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B: Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 121:257-262, 1993
32. Himmelfarb J, McMonagle E, McMenamin E: Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 58:2571-2578, 2000
33. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC: Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 23:361-366, 1997
34. Winterbourn CC, Buss IH: Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol 300:106-111, 1999
35. Shacter E, Williams JA, Lim M, Levine RL: Differential susceptibility of plasma proteins to oxidative modification: Examination by Western blot immunoassay. Free Radic Biol Med 17:429-437, 1994
36. 2-like compounds are produced in vivo by humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 87:9383-9387, 1990
37. Stenvinkel P: Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif 10:53-61, 2001
38. Gabay C, Kushner I: Acute phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454, 1999
39. Castell JV, Gómez-Lechon MJ, David M, Fabra R, Trullenque R, Henrich P: Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12:1179-1186, 1990
40. Weinhold B, Rüther U: Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J 327:425-429, 1997
41. Annuk M, Zilmer M, Lind L, Linde T, Fellstrom B: Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 12:2747-2752, 2001
42. Mezzano D, Pais EO, Aranda E, et al: Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60:1844-1850, 2001
43. 2-isoprostanes in patients on long-term hemodialysis. Kidney Int 51:1960-1966, 2001
44. 2 isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol 88:190-197, 2002
45. Soriani M, Pietraforte D, Minetti M: Antioxidant potential of anaerobic human plasma: Role of serum albumin and thiols as scavengers of carbon radicals. Arch Biochem Biophys 312:180-188, 1994
46. Frei B, Stocker R, Ames BN: Small molecule antioxidant defenses in human extracellular fluids, in Scandalios J (ed): The Molecular Biology of Free Radical Scavenging Systems. Plainview. NY, Cold Spring Harbor Laboratory Press. 1992, pp 23-45
47. Halliwell B, Gutteridge JMC: The antioxidants of human extracellular fluids. Arch Biochem Biophys 280:1-8, 1990
48. van der Vliet A, Hu ML, O'Neill CA, Cross CE, Halliwell B: Interactions of human blood plasma with hydrogen peroxide and hypochlorous acid. J Lab Clin Med 124:701-707, 1994
49. 2-isoprostanes and plasma antioxidant potential. Nephrol Dial Transplant 16:1626-1630, 2001
50. Morrow JD, Chen Y, Brame CJ, et al: The isoprostanes: Unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Rev 31:117-139, 1999
51. Heinecke JW: Oxidized amino acids: Culprits in human atherosclerosis and indicators of oxidative stress. Free Radic Biol Med 32:1090-1101, 2002
52. Himmelfarb J, McMonagle E: Manifestations of oxidant stress in uremia. Blood Purif 19:200-205, 2001
53. Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales LM, Levin NW: Relationships among inflammation, nutrition, and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 61:2240-2249, 2002